Richman D D
Department of Pathology, San Diego VA Medical Center and University of California San Diego, La Jolla 92037-0679, USA.
Antivir Ther. 2000 Mar;5(1):27-31.
HIV drug resistance testing is becoming an integral part of antiretroviral drug development and of patient management. The parameters that characterize the performance of both phenotypic and genotypic assays and the validation of this performance are essential to their proper use for these applications. Several principles and biological factors impacting drug resistance testing are summarized. Considerations regarding quality control and validation of the performance of genotypic and phenotypic assays are also addressed.
HIV耐药性检测正成为抗逆转录病毒药物研发和患者管理不可或缺的一部分。表征表型和基因型检测性能的参数以及这种性能的验证对于将它们正确用于这些应用至关重要。总结了影响耐药性检测的几个原则和生物学因素。还讨论了关于基因型和表型检测性能的质量控制和验证的注意事项。